| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Macure Pharma ApS, Macure Pharma ApS, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Orifarm A/S | 284.601.687 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |